Patient FAQs Partner Enquiry
New to the Australian market. Partner clinics now onboarding.

One harvest. Three regenerative outputs. Endless clinical possibilities.

Stem Life™ uses a single, closed-system device that turns one short procedure into three distinct regenerative tissue outputs, SVF, MFAT, and nanofat, so a specialist practitioner can match the biology to the clinical goal, from deep tissue regeneration to fine skin quality, all from the same session.

Explore the Technology Partner With Us
3Regenerative outputs, one harvest
100%Closed-system processing
12–48Months, sustained clinical results
ZeroForeign material introduced

Curious what this treats and how it works?

Explore the technology behind SVF, MFAT and nanofat, and the specific applications each output is suited to.

Start with the Technology

Considering MyStem for your practice?

Review the deployment model, training pathway, and regulatory alignment built for practices of any size or volume, and see whether this fits your clinic.

See Partnership Details
Understanding the Technology

Not one output. Three, from a single procedure.

Most regenerative aesthetic devices on the market produce a single tissue output, nanofat only, or structural fat only. MyStem's closed-loop mechanical system is built to produce three, from the one harvest, in the one session, so the clinical goal determines the output rather than the equipment on hand.

Close focus on hands, representing deep structural regeneration

SVF

Stromal vascular fraction, isolated from adipose tissue for deep regenerative applications.

SVF is the cellular fraction isolated from harvested adipose tissue, used where the clinical goal is deep structural or musculoskeletal regeneration rather than surface skin quality. Processing is entirely closed-system, with no culturing or external additives, yielding a same-session, autologous output.

Elegant neckline, representing volume restoration and skin quality

MFAT

Micro-fragmented adipose tissue, delivering structural volume with sustained integration.

MFAT is suited to structural volume restoration, integrating biologically rather than sitting as a foreign filler with a fixed degradation schedule. Published follow-up across the reviewed literature shows results sustained at 12 to 48 months, without a repeat procedure.

Close focus on face, representing fine surface skin quality

Nanofat

Emulsified fat for fine-detail skin quality work where minimal volume is required.

Nanofat is emulsified to a fine particle size suited to superficial skin-quality work, texture, fine lines, and tone, where minimal added volume is the goal. It is often combined with SVF or MFAT within the same session for a layered result.

Where regeneration transforms.

Facial Rejuvenation

Targets volume loss, fine lines, and skin quality across the face, combining MFAT for structural support with nanofat for surface refinement, matched to your consultation goals.

Hands & Décolletage

Restores structural volume and skin quality in areas that show age early and are frequently overlooked in broader facial treatment plans, using the same closed-system harvest.

Neck Rejuvenation

Addresses laxity and volume loss through the neck using the same closed-system harvest and reinjection approach used elsewhere on this page, in a single session.

Scar & Skin Repair

Supports tissue quality and texture in areas affected by scarring, using the same regenerative outputs applied elsewhere on this page, matched to the specific tissue goal.

Hair Regeneration

Uses the regenerative outputs from the same harvest to support scalp health and hair density, as part of a broader treatment plan discussed during your consultation.

Combination Programs

Because one harvest yields three outputs, a single session can address more than one goal at once, structural volume, skin quality, and targeted repair, without a second procedure.

What happens on the day, and after.

  1. Consultation & clinical assessment

  2. Local anaesthetic administered

  3. Small-volume tissue harvest

  4. Closed-system processing (15–20 min)

  5. Precision reinjection

  6. Discharge & aftercare

Will it calcify? Could it cause complications?

What the published evidence shows

Closed-system, minimally-manipulated processing is associated with a well-characterised, published safety profile across the reviewed literature.

What this means in practice

Structured patient selection and closed-system technique are the primary controls used to manage the risks documented in that literature.

TGA-sponsored CE-marked (EU MDR) ISO 13485

The published evidence behind every claim.

Every clinical statement on this site is grounded in published, peer-reviewed literature rather than testimonial or influencer-style claims, consistent with current Australian advertising standards for cosmetic procedures.

MFAT structural retention, 12–48 month follow-up cohort.
SVF regenerative outcomes, closed-system processing literature.
Nanofat skin-quality outcomes, published clinical series.
Closed-system safety profile, minimally-manipulated tissue review.

For Clinicians & Clinics.

A partnership model built around your existing practice, not a franchise you have to reshape your clinic around.

  • Deployment matched to your practice

    Fixed or mobile deployment options suited to your practice's preference and volume.

  • Clinical training and credentialing

    Structured training on harvest technique, closed-system processing, and injection protocol for all three outputs, before your first case.

  • Outcomes registry participation

    Documented, evidence-based outcomes are now the primary compliant path to market cosmetic results in Australia.

  • Regulatory alignment already in place

    The device is TGA-sponsored for orthopaedic and aesthetic use and CE-marked under EU MDR, ISO 13485 certified. Your practice adopts an already-aligned framework rather than building one from scratch.

  • Flexible deployment

    Fixed in-clinic installation or a mobile deployment option, suited to practices not ready to commit to permanent infrastructure.

  • A genuine category differentiator

    Most comparable devices on the market are limited to a single output. Three outputs from one procedure lets you serve a wider range of patient goals from one piece of equipment.

Partner enquiry.

Tell us about your practice and a member of the Stem Life™ team will be in touch to discuss deployment options.

Frequently Asked Questions

The questions we hear most often.

Honest, clinically grounded answers, for patients weighing up the treatment and for clinicians weighing up the partnership.

Patient What's the difference between SVF, MFAT, and nanofat, and how do I know which one I need?
Your practitioner selects the output, or combination of outputs, based on your clinical goal during consultation, whether that's deep structural volume, fine skin quality, or a combination of both.
Patient How long do results last? Will I need maintenance treatments?
Clinical evidence on MFAT shows results sustained at 12 to 48 months. Because the tissue integrates biologically rather than degrading on a fixed schedule, results carry no built-in expiry date.
Patient Will it calcify, form nodules, or become necrotic?
Your practitioner will discuss the specific risk profile relevant to your case as part of consultation, referencing the published, peer-reviewed evidence covered in the Safety section above.
Patient Is this procedure regulated in Australia?
Yes. The device is TGA-sponsored, and treatments are performed under medical supervision at independently operated partner clinics, in line with applicable TGA advertising and clinical guidelines.
Patient What underlying medical conditions would exclude me from this treatment?
A full clinical assessment during consultation determines your suitability for treatment. This website provides general information only and does not replace personalised medical advice from your practitioner.
Clinician What training and credentialing is required before my first case?
Structured training covers harvest technique, closed-system processing, and injection protocol across all three outputs, delivered before your first supervised case. See the training item above for the full pathway.
Clinician Do we need to buy fixed clinic infrastructure, or is a mobile option available?
Both. Deployment is matched to your practice's preference and case volume, fixed in-clinic installation or a mobile option for practices not yet ready to commit to permanent infrastructure.
Clinician How does this satisfy current advertising and regulatory obligations?
The device is TGA-sponsored for orthopaedic and aesthetic use and CE-marked under EU MDR, ISO 13485 certified. Outcomes registry participation gives your practice a documented, evidence-based alternative to testimonial marketing.
Clinician How is this different from the single-output devices we already use?
Most comparable devices produce a single tissue output. MyStem produces three, SVF, MFAT, and nanofat, from one harvest in one session, serving a wider range of patient goals.
Clinician Who do we contact to start the partner enquiry process?
Use the Partner Enquiry form above and a member of the Stem Life™ team will follow up directly to discuss deployment options tailored to your practice.
Get Started

Whether you're a patient or a practitioner, the conversation starts here.

Register your interest for treatment information, or enquire about bringing MyStem to your clinic.

Patient Information Practitioner Enquiry